Patient Adherence Program Design

Not Found

Sorry, but no results were found. Please use our navigation or search to find what you are looking for.

CVS announced voluntary removal of some phenylephrine products from shelves. How will competing pharmacies react?

Slowly follow phenylephrine removal: 40.0%

No action – wait for FDA decision: 46.7%

Pharmacies will trim low selling inventory: 13.3%

Pharmacies will increase inventory to capture sales: 0%

What is the greatest challenge for prescription digital therapeutics?

Payer coverage: 57%

Provider willingness to prescribe: 14%

Patient acceptance of use: 0%

Distribution outside normal channels: 29%

How will Artificial Intelligence tools impact health care in 2024?

Drastic increase health provider productivity: 0%

Selective use cases and minor positive impact: 66.6%

Negative impact due to errors: 16.7%

No uptake and impact: 16.7%